Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine

被引：11

作者：

Winokur, Patricia L. ^{[1
,2
]}

Patel, Shital M. ^{[3
,4
]}

Brady, Rebecca ^{[5
]}

Chen, Wilbur H. ^{[6
]}

El-Kamary, Samer S. ^{[6
]}

Edwards, Kathryn ^{[8
]}

Creech, C. Buddy ^{[8
]}

Frey, Sharon

Keitel, Wendy A. ^{[4
]}

Belshe, Robert ^{[9
]}

Walter, Emmanuel ^{[10
]}

Bellamy, Abbie ^{[7
]}

Hill, Heather ^{[7
]}

机构：

[1] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA

[2] Iowa City VA Healthcare Syst, Iowa City, IA USA

[3] Baylor Coll Med, Dept Med, Houston, TX 77030 USA

[4] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA

[5] Cincinnati Childrens Hosp, Gamble Program Clin Studies, Cincinnati, OH USA

[6] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA

[7] EMMES Corp, Rockville, MD USA

[8] Vanderbilt Univ, Dept Pediat, Nashville, TN 37235 USA

[9] St Louis Univ, Dept Internal Med, St Louis, MO 63103 USA

[10] Duke Univ, Sch Med, Dept Pediat, Durham, NC USA

来源：

JOURNAL OF INFECTIOUS DISEASES | 2015年 / 212卷 / 04期

基金：

美国国家卫生研究院;

关键词：

H5N1; influenza; vaccine; prime-boost; MEMORY B-CELLS; PANDEMIC INFLUENZA; ANTIGENIC VARIANT; HUMANS;

D O I：

10.1093/infdis/jiv087

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Influenza A(H5N1) vaccination strategies that improve the speed of the immunological response and cross-clade protection are desired. We compared the immunogenicity of a single 15-mu g or 90-mu g dose of A/H5N1/Indonesia/05/05 (clade 2) vaccine in adults who were previously primed with A/H5N1/Vietnam/1203/2004 (clade 1) vaccine. High-dose vaccine resulted in significantly higher titers to both clade 1 and 2 antigens. Clade 2 titers were unaffected by the previous dose of clade 1 vaccine. Low-dose priming with a mismatched pandemic influenza A(H5N1) vaccine would improve the rapidity, magnitude, and cross-reactivity of the immunological response following a single high-dose, unadjuvanted, pandemic vaccine.

引用

页码：525 / 530

页数：6

共 50 条

[21] Intraductal infection with H5N1 clade 2.3.4.4b influenza virus
Roubidoux, Ericka Kirkpatrick
Meliopoulos, Victoria
Livingston, Brandi
Brigleb, Pamela H.
Schultz-Cherry, Stacey
JOURNAL OF VIROLOGY, 2025, 99 (03)
[22] Antigenicity and transmissibility of a novel clade 2.3.2.1 avian influenza H5N1 virus
Xu, Lili
Bao, Linlin
Yuan, Jing
Li, Fengdi
Lv, Qi
Deng, Wei
Xu, Yanfeng
Yao, Yanfeng
Yu, Pin
Chen, Honglin
Yuen, Kwok-Yung
Qin, Chuan
JOURNAL OF GENERAL VIROLOGY, 2013, 94 : 2616 - 2626
[23] An MF-59 adjuvanted H5N1 clade 1 pre-pandemic vaccine confers cross-reactive antibodies to a clade 2 H5N1 virus strain
Banzhoff, A.
Gasparini, R.
Laghi-Pasini, F.
Staniscia, T.
Durando, P.
Montomoli, E.
VACCINE, 2008,
[24] A phase I evaluation of inactivated influenza A/H5N1 vaccine administered by the intradermal or the intramuscular route
Patel, Shital M.
Atmar, Robert L.
El Sahly, Hana M.
Cate, Thomas R.
Keitel, Wendy A.
VACCINE, 2010, 28 (17) : 3025 - 3029
[25] Avian influenza A (H5N1)
de Jong, MD
Hien, TT
JOURNAL OF CLINICAL VIROLOGY, 2006, 35 (01) : 2 - 13
[26] Safety Test and Field Study of an Inactivated Oil-Adjuvanted H5N1 Avian Influenza Vaccine
Imamura, Takashi
Sakamoto, Ryuichi
Sasaki, Takashi
Kokumai, Norihide
Ohgitani, Toshiaki
Sawata, Akira
Lin, Zhifeng
Sakaguchi, Masashi
JOURNAL OF VETERINARY MEDICAL SCIENCE, 2010, 72 (11) : 1455 - 1463
[27] Prepandemic Influenza Vaccine H5N1 (Split Virion, Inactivated, Adjuvanted) [Prepandrix™]A Review of its Use as an Active Immunization Against Influenza A Subtype H5N1 Virus
Natalie J. Carter
Greg L. Plosker
BioDrugs, 2008, 22 : 279 - 292
[28] Protection Against a Challenge of Local Isolate H5N1 in Chickens Vaccinated with Inactivated H5N1+H9N2 Influenza Vaccine
Satra, J.
Chanthaworn, T.
Trakarnrungsee, S.
Thaopech, W.
Chaising, A.
15TH CONGRESS OF THE FEDERATION OF ASIAN VETERINARY ASSOCIATIONS, FAVA-OIE JOINT SYMPOSIUM ON EMERGING DISEASES, PROCEEDINGS, 2008, : P125 - P127
[29] Avian Influenza A H5N1 Virus
Loeffelholz, Michael J.
CLINICS IN LABORATORY MEDICINE, 2010, 30 (01) : 1 - +
[30] Preliminary evidence of safety and efficacy of an orally administered, heat-inactivated H5N1 influenza vaccine
Jirathitikal, Vichai
Bourinbaiar, Aldar S.
3RD VACCINE GLOBAL CONGRESS, SINGAPORE 2009, 2010, 2 (01): : 60 - 65

← 1 2 3 4 5 →